Effectiveness of seasonal 2012/13 vaccine in preventing laboratory-confirmed influenza infection in primary care in the United Kingdom:

mid-season analysis 2012/13

J. McMenamin, N. Andrews, Charles Robertson, D.M. Fleming, H. Durnall, B. von Wissmann, J Ellis, A. Lackenby, S. Cottrell, B. Smyth, Maria Zambon, C. Moore, J. M. Watson, R.G. Pebody

Research output: Contribution to journalArticle

27 Citations (Scopus)

Abstract

The early experience of the United Kingdom (UK) is that influenza B has dominated the influenza 2012/13 season. Overall trivalent influenza vaccine (TIV) adjusted vaccine effectiveness (VE) against all laboratory-confirmed influenza in primary care was 51% (95% confidence interval (CI): 27% to 68%); TIV adjusted VE against influenza A alone or influenza B alone was 49% (95% CI: -2% to 75%) and 52% (95% CI: 23% to 70%) respectively. Vaccination remains the best protection against influenza.

Original languageEnglish
Article number1
JournalEurosurveillance
Volume18
Issue number5
Publication statusPublished - 31 Jan 2013

Fingerprint

Human Influenza
Primary Health Care
Vaccines
Infection
Influenza Vaccines
Confidence Intervals
United Kingdom
Vaccination

Keywords

  • influenza B
  • flu vaccine
  • trivalent influenza vaccine
  • vaccine effectiveness

Cite this

McMenamin, J. ; Andrews, N. ; Robertson, Charles ; Fleming, D.M. ; Durnall, H. ; von Wissmann, B. ; Ellis, J ; Lackenby, A. ; Cottrell, S. ; Smyth, B. ; Zambon, Maria ; Moore, C. ; Watson, J. M. ; Pebody, R.G. / Effectiveness of seasonal 2012/13 vaccine in preventing laboratory-confirmed influenza infection in primary care in the United Kingdom: mid-season analysis 2012/13. In: Eurosurveillance. 2013 ; Vol. 18, No. 5.
@article{916f1704b27a43d2aed19a7219b685a3,
title = "Effectiveness of seasonal 2012/13 vaccine in preventing laboratory-confirmed influenza infection in primary care in the United Kingdom:: mid-season analysis 2012/13",
abstract = "The early experience of the United Kingdom (UK) is that influenza B has dominated the influenza 2012/13 season. Overall trivalent influenza vaccine (TIV) adjusted vaccine effectiveness (VE) against all laboratory-confirmed influenza in primary care was 51{\%} (95{\%} confidence interval (CI): 27{\%} to 68{\%}); TIV adjusted VE against influenza A alone or influenza B alone was 49{\%} (95{\%} CI: -2{\%} to 75{\%}) and 52{\%} (95{\%} CI: 23{\%} to 70{\%}) respectively. Vaccination remains the best protection against influenza.",
keywords = "influenza B, flu vaccine, trivalent influenza vaccine, vaccine effectiveness",
author = "J. McMenamin and N. Andrews and Charles Robertson and D.M. Fleming and H. Durnall and {von Wissmann}, B. and J Ellis and A. Lackenby and S. Cottrell and B. Smyth and Maria Zambon and C. Moore and Watson, {J. M.} and R.G. Pebody",
year = "2013",
month = "1",
day = "31",
language = "English",
volume = "18",
journal = "Eurosurveillance",
issn = "1560-7917",
number = "5",

}

McMenamin, J, Andrews, N, Robertson, C, Fleming, DM, Durnall, H, von Wissmann, B, Ellis, J, Lackenby, A, Cottrell, S, Smyth, B, Zambon, M, Moore, C, Watson, JM & Pebody, RG 2013, 'Effectiveness of seasonal 2012/13 vaccine in preventing laboratory-confirmed influenza infection in primary care in the United Kingdom: mid-season analysis 2012/13', Eurosurveillance, vol. 18, no. 5, 1.

Effectiveness of seasonal 2012/13 vaccine in preventing laboratory-confirmed influenza infection in primary care in the United Kingdom: mid-season analysis 2012/13. / McMenamin, J.; Andrews, N.; Robertson, Charles; Fleming, D.M.; Durnall, H.; von Wissmann, B.; Ellis, J; Lackenby, A.; Cottrell, S.; Smyth, B.; Zambon, Maria; Moore, C.; Watson, J. M.; Pebody, R.G.

In: Eurosurveillance, Vol. 18, No. 5, 1, 31.01.2013.

Research output: Contribution to journalArticle

TY - JOUR

T1 - Effectiveness of seasonal 2012/13 vaccine in preventing laboratory-confirmed influenza infection in primary care in the United Kingdom:

T2 - mid-season analysis 2012/13

AU - McMenamin, J.

AU - Andrews, N.

AU - Robertson, Charles

AU - Fleming, D.M.

AU - Durnall, H.

AU - von Wissmann, B.

AU - Ellis, J

AU - Lackenby, A.

AU - Cottrell, S.

AU - Smyth, B.

AU - Zambon, Maria

AU - Moore, C.

AU - Watson, J. M.

AU - Pebody, R.G.

PY - 2013/1/31

Y1 - 2013/1/31

N2 - The early experience of the United Kingdom (UK) is that influenza B has dominated the influenza 2012/13 season. Overall trivalent influenza vaccine (TIV) adjusted vaccine effectiveness (VE) against all laboratory-confirmed influenza in primary care was 51% (95% confidence interval (CI): 27% to 68%); TIV adjusted VE against influenza A alone or influenza B alone was 49% (95% CI: -2% to 75%) and 52% (95% CI: 23% to 70%) respectively. Vaccination remains the best protection against influenza.

AB - The early experience of the United Kingdom (UK) is that influenza B has dominated the influenza 2012/13 season. Overall trivalent influenza vaccine (TIV) adjusted vaccine effectiveness (VE) against all laboratory-confirmed influenza in primary care was 51% (95% confidence interval (CI): 27% to 68%); TIV adjusted VE against influenza A alone or influenza B alone was 49% (95% CI: -2% to 75%) and 52% (95% CI: 23% to 70%) respectively. Vaccination remains the best protection against influenza.

KW - influenza B

KW - flu vaccine

KW - trivalent influenza vaccine

KW - vaccine effectiveness

UR - http://www.eurosurveillance.org/ViewArticle.aspx?ArticleId=20393

M3 - Article

VL - 18

JO - Eurosurveillance

JF - Eurosurveillance

SN - 1560-7917

IS - 5

M1 - 1

ER -